More from Pfizer (thanks to Big Ticket)--In the fall of 2016 Pfizer recruited Harvard professor Ole Isacson to head up neurosciences work, celebrating the company’s commitment to making breakthrough efforts on Alzheimer’s and Parkinson’s. Isacson, though, quietly left just 9 months later, in May of last year.----Perhaps Pfizer should closely scrutinize Anavex's pipeline--to get "up to speed" in the neuroscience area